Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Vritrans MF 500mg/250mg Tablet

Prescription Icon
Prescription Required

Marketer

Vrinda Life

Salt Composition

Tranexamic Acid (500mg) + Mefenamic Acid (250mg)

Overview Vritrans MF 500mg/250mg Tablet

TranquilFlow 500mg/250mg tablets combine medications to manage heavy menstrual bleeding and associated discomfort. This formulation inhibits clot breakdown, thereby reducing excessive menstrual flow. It also suppresses pain-inducing and inflammatory chemical signals. TranquilFlow may be taken with food anytime daily, ideally at the same time each day, starting on the first day of menstruation for optimal effect. Continue as directed by your physician. Missed doses should be taken immediately upon recall; complete the entire course of treatment, even if symptoms improve. Report any lack of improvement after three consecutive menstrual cycles. Common side effects include nausea, abdominal pain, headache, nasal congestion, sinusitis, skin rash, fatigue, and musculoskeletal pain. Diarrhea is also possible; increased fluid intake is recommended to prevent dehydration. Consult your doctor if you experience no improvement in menstrual bleeding after three cycles. Prior to commencing treatment, disclose any kidney issues, vaginal bleeding disorders, pregnancy, breastfeeding, or other medications you are using. Regular eye examinations may be necessary during treatment. Alcohol consumption should be avoided.

Primary Ingredients of Vritrans MF 500mg/250mg Tablet

No text provided. Please provide the text you wish to be rephrased.

Uses of Vritrans MF 500mg/250mg Tablet

Managing excessive menstrual flow and menstrual discomfort

Major Benefits of Vritrans MF 500mg/250mg Tablet:

Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Ingest the Vritrans MF 500mg/250mg tablet whole; avoid chewing, crushing, or fracturing it. Consume it with a meal.

Common Side effects of Vritrans MF 500mg/250mg Tablet:

  • Nausea
  • Vomiting
  • Heartburn
  • Indigestion
  • Diarrhea
  • Loss of appetite
  • Nasal congestion (stuffy nose)
  • Headache
  • Tiredness
  • Musculoskeletal (bone, muscle or joint) pain
  • Anemia (low number of red blood cells)
  • Stomach pain
  • Sinus pain
  • Sinus inflammation

How to use Vritrans MF 500mg/250mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the Vritrans MF 500mg/250mg Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with food.

How Vritrans MF 500mg/250mg Tablet works:

Vritrans MF 500mg/250mg tablets contain Tranexamic Acid and Mefenamic Acid, working synergistically to manage menstrual bleeding and associated discomfort. Tranexamic Acid's antifibrinolytic action stabilizes blood clots, reducing heavy menstrual flow. Mefenamic Acid, an NSAID, inhibits prostaglandin synthesis, thereby alleviating pain and inflammation often accompanying menstruation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Vritrans MF 500mg/250mg tablets is dangerous.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Vritrans MF 500mg/250mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice before taking this medication.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Using Vritrans MF 500mg/250mg tablets while breastfeeding appears to pose minimal risk. Available human data indicates negligible infant danger from this medication.

DrivingDrivingUNSAFE

Taking Vritrans MF 500mg/250mg tablets can cause drowsiness, blurred vision, and dizziness, potentially impairing alertness. Refrain from driving if you experience these effects.

KidneyKidneyCAUTION

Patients with impaired kidney function should use Vritrans MF 500mg/250mg tablets cautiously, potentially requiring dosage modification under medical supervision. Vritrans MF 500mg/250mg tablets are contraindicated in individuals with severe renal disease.

LiverLiverSAFE IF PRESCRIBED

Vritrans MF 500mg/250mg tablets are likely safe for individuals with hepatic impairment. Current evidence indicates dose modification may be unnecessary; however, physician consultation is advised.

What if you forget to take Vritrans MF 500mg/250mg Tablet :

Should you forget to take your Vritrans MF 500mg/250mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.

Facts to Know About Vritrans MF 500mg/250mg Tablet

LabelValue
Developing Habits No.
Treatment Category KINSHIP

FAQs on Vritrans MF 500mg/250mg Tablet

Vritrans MF 500mg/250mg tablets combine tranexamic acid and mefenamic acid to relieve pain and reduce heavy menstrual bleeding in women.
Patients with severe kidney disease, active blood clots, or color vision problems should avoid it due to potential harm.
Store this medication in its original, tightly closed container, following the storage instructions on the label or packaging. Discard any unused medication; keep it out of reach of children, pets, and others.
Vritrans MF 500mg/250mg T...
156
MRP 180
13% off